<code id='C460C3D659'></code><style id='C460C3D659'></style>
    • <acronym id='C460C3D659'></acronym>
      <center id='C460C3D659'><center id='C460C3D659'><tfoot id='C460C3D659'></tfoot></center><abbr id='C460C3D659'><dir id='C460C3D659'><tfoot id='C460C3D659'></tfoot><noframes id='C460C3D659'>

    • <optgroup id='C460C3D659'><strike id='C460C3D659'><sup id='C460C3D659'></sup></strike><code id='C460C3D659'></code></optgroup>
        1. <b id='C460C3D659'><label id='C460C3D659'><select id='C460C3D659'><dt id='C460C3D659'><span id='C460C3D659'></span></dt></select></label></b><u id='C460C3D659'></u>
          <i id='C460C3D659'><strike id='C460C3D659'><tt id='C460C3D659'><pre id='C460C3D659'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:8
          Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT
          Adobe

          Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

          The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

          advertisement

          The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Listen: Biotech layoffs, eye drug drama, & gene therapy milestones
          Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

          SammyKimballforSTATCanbiotechstartupssurviveadownturn?IsCovid-19agoodbusiness?Andwhendidophthalmolog

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          A controversial new treatment promises to make little people taller

          AhminHaider(center)andhisbrotherBelalHaider(right)workontheirhomeworkwiththeircousinZayyanAgboatwall